(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is primarily used in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting the central nervous system. Its structural features make it valuable in the creation of potential therapeutic agents for neurological disorders, such as depression, anxiety, and Parkinson's disease. Additionally, it is utilized in the study of receptor binding and enzyme inhibition, aiding in the discovery of new drugs with improved efficacy and selectivity.